Detalhe da pesquisa
1.
A prognostic model for survival after salvage treatment with FLAG-Ida +/- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia.
Br J Haematol
; 174(5): 700-10, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27118319
2.
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.
Dis Markers
; 2022: 3132941, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36051360
3.
Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study.
Hemasphere
; 5(3): e538, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33604516
4.
Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality.
Blood Cancer J
; 10(10): 103, 2020 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077708
5.
Compresión medular por sarcoma granulocítico primario / Spinal cord compression due to nonleukemic granulocytic sarcoma
Rev. colomb. cancerol
; 19(4): 239-243, oct.-dic, 2015. ilus, tab
Artigo
em Espanhol
| LILACS | ID: lil-769100